About Gilead Sciences, Inc.
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes antiviral and immunology-based therapeutic drugs for treatment of life-threatening diseases. The company focuses on therapeutic areas including human immunodeficiency virus and acquired immunodeficiency syndrome, hepatitis B and hepatitis C, influenza, coronavirus disease 2019, oncology, and inflammation-related respiratory and cardiovascular conditions. Gilead develops and markets pharmaceutical products including treatments for HIV infection, hepatitis, cancer, and other serious illnesses under brand names including Biktarvy, Genvoya, Descovy, and Trodelvy. The company operates manufacturing and research facilities and maintains commercial operations across the United States, Europe, Canada, Asia-Pacific, the Middle East, and Africa, serving physicians, hospitals, clinics, and other healthcare providers. The company employs more than 17,600 employees worldwide. Gilead was founded in 1987 and is headquartered in Foster City, California, United States.